PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AI can predict premature deaths in people with inflammatory bowel disease

2025-03-24
(Press-News.org) Almost half of people who died with inflammatory bowel disease (IBD) died prematurely, according to a study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241117 that used machine learning models to predict death.

Canada has some of the highest rates of IBD worldwide, which includes Crohn disease and ulcerative colitis. People with IBD have shorter life expectancy than people without such diseases, and they can develop other chronic health conditions related to their IBD. The study found that people with IBD are at risk for premature death (defined as death before age 75) when they develop other chronic health conditions earlier in life.

As machine learning models can predict premature death in the general population, researchers applied the technology to determine whether it could predict premature deaths among people in Ontario with IBD and other chronic conditions using health care data held at ICES. 

“The clinical implication is that chronic conditions developed early in life may be more important in determining a patient’s health trajectory, although further causal research is needed to elucidate this relationship,” writes Dr. Eric Benchimol, a pediatric gastroenterologist and senior scientist at The Hospital for Sick Children (SickKids), professor of pediatrics and epidemiology at the Temerty Faculty of Medicine, University of Toronto, and a senior core scientist at ICES. “Although our insights are not causal insights, they identify patients potentially at higher risk of premature death, and therefore who might benefit from more coordinated care of their IBD and other chronic conditions,” he says.

Of the total 9278 deaths in people with IBD between 2010 and 2020, almost half (47%) were premature, with higher rates in males than in females (50% v. 44%). The most common chronic conditions at death were various types of arthritis (77%), hypertension (73%), mood disorders (69%), kidney failure (50%) and cancer (46%). The researchers found that including chronic conditions diagnosed before age 60 and the age of diagnosis improved the models’ predictions.

“The use of premature death as the outcome more directly identifies opportunities for health system improvements, as premature deaths are considered avoidable through appropriate prevention or early and effective treatment,” write the authors.

The study was co-led by medical student Gemma Postill of the Temerty Faculty of Medicine, and Dr. Laura Rosella, professor and Canada Research Chair in Population Health Analytics at the Dalla Lana School of Public Health.

The authors hope that their research will help pinpoint areas for more targeted follow up from a range of health care professionals, from dietitians to mental health professionals and specialists when required.

“These findings provide scientific support for providing multidisciplinary and integrated health care across the lifespan (particularly during young and middle adulthood),” the authors conclude.

END


ELSE PRESS RELEASES FROM THIS DATE:

Household electricity three times more expensive than upcoming ‘eco-friendly’ aviation e-fuels, study reveals

2025-03-24
Existing tax policies during the energy transition from fossil fuels to renewable sources will lead to major energy injustices and skewed priorities, new research published in Climate Policy shows. The peer-reviewed study found that electricity serving primary needs, such as heating or lighting, ultimately costs three times more than electricity for tertiary needs such as long-distance mobility – mostly due to taxation policies. Further highlighting the ongoing social inequalities of fuel and related policies, the findings also demonstrate within the European Union (EU), the wealthiest 1% of all its population is responsible for 66% of the distance ...

Urine test could halve post-op scans for kidney cancer

2025-03-24
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown. The findings are presented today [Monday 24 March 2025] at the European Association of Urology (EAU) Congress in Madrid and have been accepted for publication in European Urology Oncology. The test analyses the distinctive profiles of certain types of sugar molecules, called glycosaminoglycans which are found in urine. These profiles are known as the GAGome. The international AURORAX-0087A (AUR87A) study is assessing whether a GAGome test can accurately detect ...

Thousands of lives could be saved by combining two cholesterol-lowering drugs

Thousands of lives could be saved by combining two cholesterol-lowering drugs
2025-03-23
London, UK: The largest analysis to examine the best way to lower levels of ‘bad’ cholesterol in patients with blocked arteries shows that they should immediately be given a combination of a statin and another drug called ezetimibe, rather than statins alone. This could prevent thousands of deaths a year from heart attacks, strokes and other cardiovascular diseases. The meta-analysis of 108,353 patients in 14 studies who were at very high risk of suffering heart attack or stroke, or who had already suffered one of these cardiovascular events is published in the journal Mayo Clinic Proceedings ...

High resolution ultrasound could enable faster prostate cancer diagnosis

2025-03-23
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is cheaper and easier to use than MRI. It could significantly speed up diagnosis, reduce the need for multiple hospital visits and free up MRI for other uses, researchers say. The results of the OPTIMUM trial are presented today [Sunday 23 March 2025] at the European Association of Urology Congress in Madrid and published in JAMA. OPTIMUM is the first randomised trial to compare micro-ultrasound (microUS) guided biopsy with ...

Guardians of the vineyard: Canines and chemistry work to combat powdery mildew

2025-03-23
SAN DIEGO, March 23, 2025 — Dogs have many jobs but one you may not expect is identifying grapevines coated in a destructive and highly contagious fungus. Although dogs can detect serious vine infections by smell, scientists don’t know exactly what odor molecules are triggering the response. Researchers are now analyzing volatile chemicals emanating from grape leaves infected by a fungus called powdery mildew with the goal of improving training for vineyard canines. Nayelly Rangel, a graduate student at Texas Tech University, will present the team’s results at the spring meeting of the American Chemical Society (ACS). ACS Spring 2025 is being held ...

Improving GLP-1 drug delivery by ‘painting’ it on antibodies

2025-03-23
SAN DIEGO, March 23, 2025 — Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs have made it difficult for people to start and maintain treatment. Now, researchers report a drug delivery system that “paints” these peptides directly on the antibodies they target. In studies with mice, the system led to sustained weight loss and prolonged blood sugar management with a GLP-1 injection one fourth that of the standard dose. Bradley Pentelute, professor of chemistry at the Massachusetts Institute of Technology (MIT), will present his team’s results at the spring ...

Second TB vaccination boosts immunity in bladder cancer patients and reduces cancer recurrence

2025-03-23
Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly improve patient outcomes for the most common type of bladder cancer, according to a pilot study of 40 patients. Initial results from the RUTIVAC-1 Trial are presented today [Sunday 23 March 2025] at the European Association of Urology (EAU) Congress in Madrid. In the randomised controlled trial, administering the vaccine alongside standard treatment led to an elevated immune response, which is known to improve the body’s ability to suppress future tumours. Patients who received the vaccine had no discernible ...

Study of UK biobank reveals link between new-onset type 2 diabetes and some but not all obesity-related cancers

2025-03-22
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that a new diagnosis of type 2 diabetes is linked to a subsequent increase in the risk of developing some, but not all, obesity related cancers. The study is by Owen Tipping, University of Manchester, UK, and Professor Andrew Renehan, National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester, UK, and colleagues. Previous research has described associations between type 2 diabetes mellitus (T2D) and higher risk of several obesity-related cancers ...

Waist circumference stronger risk marker than BMI for obesity-related cancer in men, but not women

2025-03-22
Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) and published in The Journal of the National Cancer Institute shows that waist circumference (WC) is a stronger risk marker than BMI for developing obesity-related cancers in men, but not women. The study was conducted by Dr Ming Sun, Dr Josef Fritz and Dr Tanja Stocks, Lund University, ...

Uncomfortable bladder tests for female incontinence can be avoided, say researchers

2025-03-22
Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of non-invasive assessments work just as well in guiding treatment. Led by researchers at the University of Aberdeen, the findings of the FUTURE Trial are presented today (Saturday 22 March 2025) at the European Association of Urology (EAU) Congress in Madrid and published in The Lancet. The UK study is the world’s first randomised controlled trial of the clinical and cost-effectiveness of invasive urodynamics testing. It focuses on a group of women with ...

LAST 30 PRESS RELEASES:

Government of Guyana, Mount Sinai Health System and Hess Corporation announce five-year extension of national healthcare initiative.

Preclinical study: after heart attack, a boost in anti-inflammatory cells promoted healing

Glucose revealed as a master regulator of tissue regeneration in Stanford Medicine study

Open-label placebo appears to reduce premenstrual symptoms, study suggests

New mums advised to do two hours of moderate to vigorous exercise a week

Milk as Medicine: New Study Shows Breast Milk Transforms Challenges into Triumphs

CU Cancer Center researchers identify the ‘switch’ that allows intestinal cells to regenerate after injury

Special issue of Academic Emergency Medicine explores the science of errors in emergency care

Organoid fusions as models to study meninges-brain signaling

A multimodal light manipulator

OU researcher leverages technology for alcohol disorder interventions in primary care

Automated lead nurturing boosts sales—but only under the right conditions

Lessons from Venezuela’s democratic collapse: How opposition movements can defy autocratic leaders

USU ecologists document Utah's bee species and say beehive state is rich in bee diversity

A hit of dopamine tells baby birds when their song practice is paying off

Basketball analytics investment is key to NBA wins and other successes

Scientific cooperation is strategic for Brazil to strengthen relations with Europe

Engineering antibodies with a novel fusion protein

Transforming cardiovascular care through upfront combination therapy

URI to host international XV Progress in Motor Control Conference

How Zika virus knocks out our immune defenses

Could an arthritis drug unlock lasting relief from epilepsy and seizures? UW–Madison researchers see promising results in mice

SCAI announces 2025-26 recipients of JSCAI Editorial Fellowship Program

Study unravels mystery of cancer-fueling enzyme—could lead to new therapies

Lupus-related antibody shows promise in enhancing cancer treatment efficacy

BESSY II: Magnetic ‘microflowers’ enhance local magnetic fields

New study may help predict cardiometabolic disease risk and personalize prevention strategies

The Frontiers of Knowledge Award goes to Avelino Corma, John Hartwig and Helmut Schwarz for their founding work on the catalysts that are enabling a more efficient, sustainable chemistry

New software finds aging cells that contribute to disease and health risks

UTA inventors recognized worldwide for innovations

[Press-News.org] AI can predict premature deaths in people with inflammatory bowel disease